Open in app
Sign inGet started
Mental health in a time of COVID-19

Mental health in a time of COVID-19

Whether you’re on lockdown or just practicing social distancing, chances are you’re beginning to feel the strain.
Go to the profile of ATAI MEDIA
ATAI MEDIA
EntheogeniX Biosciences gets going

EntheogeniX Biosciences gets going

Psilocybin, ibogaine, and many other psychedelic substances have yielded remarkable early signals of their efficacy in treating everything…
Go to the profile of ATAI MEDIA
ATAI MEDIA
Reflections on the progress of psychedelic medicine

Reflections on the progress of psychedelic medicine

Since co-founding ATAI Life Sciences, I’ve been a firm believer in the power of psychedelic medicine to transform the way we understand…
Go to the profile of ATAI MEDIA
ATAI MEDIA
Terence Kelly appointed CEO of ATAI platform company Perception Neuroscience

Terence Kelly appointed CEO of ATAI platform company Perception Neu...

(originally published on ATAI.life on February 7, 2020)
Go to the profile of ATAI MEDIA
ATAI MEDIA
ATAI Life Sciences Announces Joint Venture with DemeRx to Develop Ibogaine For Opioid Use Disorder

ATAI Life Sciences Announces Joint Venture with DemeRx to Develop I...

BERLIN and MIAMI, Jan. 24, 2020 /PRNewswire/ — ATAI Life Sciences AG (“ATAI” or the “Company”), a global biotech platform that envisions…
Go to the profile of ATAI MEDIA
ATAI MEDIA
GABA Therapeutics commences phase I study of Etifoxine

GABA Therapeutics commences phase I study of Etifoxine

(Originally published on ATAI.life on January 16, 2020)
Go to the profile of ATAI MEDIA
ATAI MEDIA
ATAI’s Chief Scientific Officer addresses the future of psychiatric drug development at ISAD19

ATAI’s Chief Scientific Officer addresses the future of psychiatric...

(originally published on ATAI.life on November 23, 2019)
Go to the profile of ATAI MEDIA
ATAI MEDIA
ATAI Life Sciences and Cyclica launch joint venture to revolutionize drug development for mental…

ATAI Life Sciences and Cyclica launch joint venture to revolutioniz...

Berlin and Toronto, November 11, 2019
Go to the profile of ATAI MEDIA
ATAI MEDIA
Social Comparisons: Effects on Mental Health

Social Comparisons: Effects on Mental Health

(Originally published on ATAI.life on November 2, 2019)
Go to the profile of ATAI MEDIA
ATAI MEDIA
Gender Disparities and Mental Health Risk Factors

Gender Disparities and Mental Health Risk Factors

(Originally published on ATAI.life October 26, 2019)
Go to the profile of ATAI MEDIA
ATAI MEDIA
Inequality: An overlooked contributor to mental health disorders (part 1)

Inequality: An overlooked contributor to mental health disorders (p...

(Originally published on ATAI.life on October 12, 2019)
Go to the profile of ATAI MEDIA
ATAI MEDIA
Impact of the Depression Epidemic: Family & Community

Impact of the Depression Epidemic: Family & Community

(Originally published on ATAI.life October 18, 2019)
Go to the profile of ATAI MEDIA
ATAI MEDIA
Let’s take a closer look at psilocybin

Let’s take a closer look at psilocybin

“Magic mushrooms” have officially entered the mainstream. Proponents in the media now regularly extol their potential for alleviating…
Go to the profile of ATAI MEDIA
ATAI MEDIA
Burdens of Depression: The Individual

Burdens of Depression: The Individual

Depression is today’s most prevalent mental health disorder and the leading cause of disability worldwide. Painful both mentally and…
Go to the profile of ATAI MEDIA
ATAI MEDIA
Digital Depression — The Modern Dilemma

Digital Depression — The Modern Dilemma

The last twenty years — the digital age — have fundamentally changed the way we interact with those around us, our surroundings and…
Go to the profile of ATAI MEDIA
ATAI MEDIA
Consequences of the Youth Mental Health Crisis

Consequences of the Youth Mental Health Crisis

Adolescents and young adults who suffer from mental disorders often face other long-term health consequences stemming from their diseases…
Go to the profile of ATAI MEDIA
ATAI MEDIA
About #InsightNetwork | ATAI Life Sciences AGLatest StoriesArchiveAbout MediumTermsPrivacyTeams